Recent Finacing
Recent Raise
TearClear develops a preservative-free delivery system that converts preserved multi-dose topical ophthalmic formulations and advances clinical programs with lead candidates targeting glaucoma, dry eye, and allergic conjunctivitis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
